Ethanolamine Utilization and Bacterial Microcompartment Formation Are Subject to Carbon Catabolite Repression
Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella . Therefore, it is important to understand how the genes that govern EA utilization are regula...
Saved in:
Published in | Journal of bacteriology Vol. 201; no. 10; p. 1 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
15.05.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-9193 1098-5530 1098-5530 |
DOI | 10.1128/JB.00703-18 |
Cover
Abstract | Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as
Enterococcus faecalis
and
Salmonella
. Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria.
Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source.
Enterococcus faecalis
, a GI commensal and opportunistic pathogen, contains approximately 20
e
thanolamine
ut
ilization (
eut
) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in
eut
gene expression, was a concomitant increase in the number of catabolic
b
acterial
m
icro
c
ompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted
cre
site in one of the three EA-inducible promoters,
PeutS
, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the
PeutS
promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and
cre
sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR).
IMPORTANCE
Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as
Enterococcus faecalis
and
Salmonella
. Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria. |
---|---|
AbstractList | Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source.
, a GI commensal and opportunistic pathogen, contains approximately 20
thanolamine
ilization (
) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in
gene expression, was a concomitant increase in the number of catabolic
acterial
icro
ompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted
site in one of the three EA-inducible promoters,
, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the
promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and
sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR).
Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as
and
Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria. Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella . Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria. Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis , a GI commensal and opportunistic pathogen, contains approximately 20 e thanolamine ut ilization ( eut ) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic b acterial m icro c ompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS , was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR). IMPORTANCE Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella . Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria. Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis, a GI commensal and opportunistic pathogen, contains approximately 20 ethanolamine utilization (eut) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic bacterial microcompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR).IMPORTANCE Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria.Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis, a GI commensal and opportunistic pathogen, contains approximately 20 ethanolamine utilization (eut) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic bacterial microcompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR).IMPORTANCE Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria. Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis, a GI commensal and opportunistic pathogen, contains approximately 20 ethanolamine utilization (eut) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic bacterial microcompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR). |
Author | Cruz, Melissa R. Goodson, Jonathan R. Kaval, Karan Gautam Winkler, Wade C. Garsin, Danielle A. Gebbie, Margo |
Author_xml | – sequence: 1 givenname: Karan Gautam surname: Kaval fullname: Kaval, Karan Gautam organization: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA – sequence: 2 givenname: Margo surname: Gebbie fullname: Gebbie, Margo organization: Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA – sequence: 3 givenname: Jonathan R. surname: Goodson fullname: Goodson, Jonathan R. organization: Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA – sequence: 4 givenname: Melissa R. surname: Cruz fullname: Cruz, Melissa R. organization: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA – sequence: 5 givenname: Wade C. surname: Winkler fullname: Winkler, Wade C. organization: Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA – sequence: 6 givenname: Danielle A. surname: Garsin fullname: Garsin, Danielle A. organization: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA, The UT Center for Antimicrobial Resistance and Genomics, The University of Texas Health Science Center at Houston, Houston, Texas, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30833356$$D View this record in MEDLINE/PubMed |
BookMark | eNptkcFrFDEUh4NU7LZ68i4BL4JMfUkms5mL0F1aa6kIas8hk3ljs8wka5IR9K837bbFlp4CyZcfv_e-A7Lng0dCXjM4YoyrD-erI4AliIqpZ2TBoFWVlAL2yAKAs6plrdgnByltAFhdS_6C7AtQQgjZLMh0kq-MD6OZnEd6md3o_prsgqfG93RlbMbozEi_OBuDDdPWxDyhz_Q0xGkHHkek3-dugzbTHOjaxK7crk02XRhdRvoNtxFTKuxL8nwwY8JXt-chuTw9-bE-qy6-fvq8Pr6obA1trlpuRdv2sjTvhVRKSVQCDWskwDBwOYDs0TLeiKYHpRiKxgK03cCWdT00gzgkH3e527mbsLelcDSj3kY3mfhHB-P0wxfvrvTP8Fs3teItX5aAd7cBMfyaMWU9uWRxHI3HMCfNmVIclrW8Rt8-Qjdhjr6MpzkXHIobLgr15v9G91XuTBTg_Q4oe04p4nCPMNDXnvX5St941kwVmj2ircs3Oso4bnzyzz-zBqqo |
CitedBy_id | crossref_primary_10_1016_j_crmicr_2022_100157 crossref_primary_10_1128_mbio_01216_23 crossref_primary_10_1016_j_mib_2021_04_008 crossref_primary_10_1111_mmi_14962 crossref_primary_10_1128_mBio_00380_21 crossref_primary_10_1128_msystems_01349_20 crossref_primary_10_1128_IAI_00270_20 crossref_primary_10_3390_medsci10030040 crossref_primary_10_1128_ecosalplus_esp_0025_2019 crossref_primary_10_1128_jb_00047_22 crossref_primary_10_1128_msystems_00750_24 crossref_primary_10_1128_jb_00269_24 |
Cites_doi | 10.1128/JB.00838-09 10.1186/1471-2180-10-224 10.1016/0005-2760(69)90030-7 10.1128/JB.00217-11 10.1073/pnas.1107857108 10.1038/nrmicro2334 10.1128/jb.174.20.6634-6643.1992 10.1093/nar/gkp335 10.1126/science.1258494 10.1007/978-1-60761-854-6_5 10.1128/JB.00706-13 10.1128/JB.182.20.5799-5806.2000 10.1074/jbc.M202573200 10.1371/journal.pgen.1002666 10.1073/pnas.0812194106 10.1038/nrmicro.2018.10 10.1002/9780471729259.mc09d02s30 10.1128/JB.00952-08 10.1146/annurev.micro.50.1.137 10.1186/1471-2164-13-401 10.1016/j.mib.2015.12.006 10.1111/j.1462-2920.2010.02334.x 10.1128/jb.170.2.700-707.1988 10.1126/science.1255083 10.3389/fcimb.2016.00158 10.1128/jb.175.16.5216-5223.1993 10.1093/bioinformatics/btr064 10.1042/bj1760751 10.1126/science.1255091 10.1128/jb.176.15.4527-4533.1994 10.1042/bst0040495 10.1111/mmi.12537 10.1271/bbb.80479 10.1128/mBio.00066-18 10.1093/nar/gks864 10.1099/00222615-34-3-143 10.1016/j.plasmid.2006.08.003 10.1371/journal.pcbi.1003898 10.1128/mBio.00414-18 |
ContentType | Journal Article |
Copyright | Copyright © 2019 American Society for Microbiology. Copyright American Society for Microbiology May 2019 Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2019 American Society for Microbiology. – notice: Copyright American Society for Microbiology May 2019 – notice: Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7TM 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
DOI | 10.1128/JB.00703-18 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Catabolite Repression of Ethanolamine Utilization |
EISSN | 1098-5530 |
ExternalDocumentID | PMC6482927 30833356 10_1128_JB_00703_18 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI110432 – fundername: ; grantid: R01AI110432 |
GroupedDBID | --- -DZ -~X .55 0R~ 18M 29J 2WC 39C 4.4 53G 5GY 5RE 5VS 79B 85S AAGFI AAYXX ABPPZ ACGFO ACGOD ACNCT ACPRK ADBBV AENEX AFRAH AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BKOMP BTFSW CITATION CJ0 CS3 DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 L7B O9- OK1 P-S P2P PQQKQ RHI RNS RPM RSF RXW TAE TR2 UHB UKR UPT W8F WH7 WOQ X7M YQT YR2 YZZ ZCA ~02 ~KM CGR CUY CVF ECM EIF NPM RHF UCJ VQA YIN 7QL 7TM 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c409t-92c399d5193d358885e83ea16500ff25f05dec12636d0881e36c009bf1744f6f3 |
ISSN | 0021-9193 1098-5530 |
IngestDate | Thu Aug 21 18:33:09 EDT 2025 Thu Sep 04 14:27:48 EDT 2025 Mon Jun 30 10:32:46 EDT 2025 Wed Feb 19 02:31:06 EST 2025 Tue Jul 01 02:56:29 EDT 2025 Thu Apr 24 22:52:34 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | carbon catabolite repression bacterial microcompartments ethanolamine utilization enterococcus |
Language | English |
License | Copyright © 2019 American Society for Microbiology. All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c409t-92c399d5193d358885e83ea16500ff25f05dec12636d0881e36c009bf1744f6f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 K.G.K. and M.G. contributed equally to this work. Citation Kaval KG, Gebbie M, Goodson JR, Cruz MR, Winkler WC, Garsin DA. 2019. Ethanolamine utilization and bacterial microcompartment formation are subject to carbon catabolite repression. J Bacteriol 201:e00703-18. https://doi.org/10.1128/JB.00703-18. |
OpenAccessLink | https://jb.asm.org/content/jb/201/10/e00703-18.full.pdf |
PMID | 30833356 |
PQID | 2232000723 |
PQPubID | 40724 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6482927 proquest_miscellaneous_2188207457 proquest_journals_2232000723 pubmed_primary_30833356 crossref_primary_10_1128_JB_00703_18 crossref_citationtrail_10_1128_JB_00703_18 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-05-15 |
PublicationDateYYYYMMDD | 2019-05-15 |
PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of bacteriology |
PublicationTitleAlternate | J Bacteriol |
PublicationYear | 2019 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | White DA (e_1_3_3_5_2) 1973 DebRoy S (e_1_3_3_16_2) 2014 e_1_3_3_17_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_40_2 Ramsey M (e_1_3_3_26_2) 2014 e_1_3_3_6_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_43_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_41_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 |
References_xml | – ident: e_1_3_3_2_2 doi: 10.1128/JB.00838-09 – ident: e_1_3_3_30_2 doi: 10.1186/1471-2180-10-224 – ident: e_1_3_3_4_2 doi: 10.1016/0005-2760(69)90030-7 – ident: e_1_3_3_20_2 doi: 10.1128/JB.00217-11 – ident: e_1_3_3_7_2 doi: 10.1073/pnas.1107857108 – ident: e_1_3_3_10_2 doi: 10.1038/nrmicro2334 – ident: e_1_3_3_19_2 doi: 10.1128/jb.174.20.6634-6643.1992 – volume-title: Enterococci: from commensals to leading causes of drug resistant infection year: 2014 ident: e_1_3_3_16_2 – ident: e_1_3_3_40_2 doi: 10.1093/nar/gkp335 – ident: e_1_3_3_12_2 doi: 10.1126/science.1258494 – ident: e_1_3_3_43_2 doi: 10.1007/978-1-60761-854-6_5 – volume-title: Enterococci: from commensals to leading causes of drug resistant infection year: 2014 ident: e_1_3_3_26_2 – ident: e_1_3_3_28_2 doi: 10.1128/JB.00706-13 – ident: e_1_3_3_29_2 doi: 10.1128/JB.182.20.5799-5806.2000 – ident: e_1_3_3_24_2 doi: 10.1074/jbc.M202573200 – ident: e_1_3_3_11_2 doi: 10.1371/journal.pgen.1002666 – ident: e_1_3_3_9_2 doi: 10.1073/pnas.0812194106 – ident: e_1_3_3_27_2 doi: 10.1038/nrmicro.2018.10 – start-page: 441 volume-title: Form and function of phospholipids year: 1973 ident: e_1_3_3_5_2 – ident: e_1_3_3_35_2 doi: 10.1002/9780471729259.mc09d02s30 – ident: e_1_3_3_8_2 doi: 10.1128/JB.00952-08 – ident: e_1_3_3_34_2 doi: 10.1146/annurev.micro.50.1.137 – ident: e_1_3_3_41_2 doi: 10.1186/1471-2164-13-401 – ident: e_1_3_3_13_2 doi: 10.1016/j.mib.2015.12.006 – ident: e_1_3_3_6_2 doi: 10.1111/j.1462-2920.2010.02334.x – ident: e_1_3_3_25_2 doi: 10.1128/jb.170.2.700-707.1988 – ident: e_1_3_3_15_2 doi: 10.1126/science.1255083 – ident: e_1_3_3_22_2 doi: 10.3389/fcimb.2016.00158 – ident: e_1_3_3_36_2 doi: 10.1128/jb.175.16.5216-5223.1993 – ident: e_1_3_3_42_2 doi: 10.1093/bioinformatics/btr064 – ident: e_1_3_3_18_2 doi: 10.1042/bj1760751 – ident: e_1_3_3_14_2 doi: 10.1126/science.1255091 – ident: e_1_3_3_21_2 doi: 10.1128/jb.176.15.4527-4533.1994 – ident: e_1_3_3_17_2 doi: 10.1042/bst0040495 – ident: e_1_3_3_32_2 doi: 10.1111/mmi.12537 – ident: e_1_3_3_37_2 doi: 10.1271/bbb.80479 – ident: e_1_3_3_3_2 doi: 10.1128/mBio.00066-18 – ident: e_1_3_3_31_2 doi: 10.1093/nar/gks864 – ident: e_1_3_3_23_2 doi: 10.1099/00222615-34-3-143 – ident: e_1_3_3_38_2 doi: 10.1016/j.plasmid.2006.08.003 – ident: e_1_3_3_33_2 doi: 10.1371/journal.pcbi.1003898 – ident: e_1_3_3_39_2 doi: 10.1128/mBio.00414-18 |
SSID | ssj0014452 |
Score | 2.383193 |
Snippet | Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize... Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. , a GI commensal and... Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1 |
SubjectTerms | Bacteria Bacteriology Bioinformatics Carbon Catabolite Repression Culture Media - chemistry Deletion mutant Energy sources Enterococcus faecalis - genetics Enterococcus faecalis - growth & development Enterococcus faecalis - metabolism Ethanolamine Ethanolamine - metabolism Gastrointestinal tract Gene Deletion Gene expression Gene Expression Regulation, Bacterial Genes Genes, Regulator Genetic Complementation Test Operons Opportunist infection Organic chemistry Predictive control Promoters Protein A Proteins Ribonucleic acid RNA Structural proteins Target recognition Utilization |
Title | Ethanolamine Utilization and Bacterial Microcompartment Formation Are Subject to Carbon Catabolite Repression |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30833356 https://www.proquest.com/docview/2232000723 https://www.proquest.com/docview/2188207457 https://pubmed.ncbi.nlm.nih.gov/PMC6482927 |
Volume | 201 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1098-5530 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014452 issn: 0021-9193 databaseCode: KQ8 dateStart: 19160101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1098-5530 dateEnd: 20250330 omitProxy: true ssIdentifier: ssj0014452 issn: 0021-9193 databaseCode: DIK dateStart: 19160101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1098-5530 dateEnd: 20250330 omitProxy: true ssIdentifier: ssj0014452 issn: 0021-9193 databaseCode: GX1 dateStart: 19160101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1098-5530 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0014452 issn: 0021-9193 databaseCode: RPM dateStart: 19160101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbKEBIviN8UBjLSxAMoI3Fqx3lcq3ZT2cZLK_UtshNHTGqTUVIk-J_4H7mLnTQdBQEvUWVbjeX7cr6z77sj5CjLdawjvDME_e8NchZ7MtPcS2PNcb8zss5bcHEpzuaD6YIver0fnailTaWP0-97eSX_I1VoA7kiS_YfJNv-KTTAb5AvPEHC8PwrGY_x3Bt80xWaivPqaulIlfWNwNDmYUbuLQbd2WBzG1M-aRiL707WBnUHHsagFTpSaw2tI1UBNpCdjAa6jZQtfmPGavuandP5D-qrWjqqGeiPU7Wp1KqN9DFa20sRLLJbts1l2bC_mhP9bTDjaL2pD7ovzBKAolyHO6xAfhT3LF2zww9AxdUJSa0XQXfm2dAMAtDEtnzisbHaGZOfYp2jrvpm7jDE4dTvaONg_x7BkPcwHWLWdAzMk9utsLn-v_yYTObn58lsvJi9uf7sYZEyvMx3FVtukdssEgILZpwu2ogicE25S05vZ-7ooPC-95237RpAv3g1N4NzO9bO7D655-RLTyzmHpCeKR6SO7Zw6bdHZNVFHu0gjwLyaIs8ehN5tEUe_LWhDnm0KqlFHt0ij26R95jMJ-PZ6MxzhTu8dODHlRezFOzeDJ2DLORSSm5kaFQA3oCf54znPs9MGjARigx2ucCEIgVbX-fgHg9ykYdPyEFRFuYZoVzmIkpVygR0KZZr5oc8hTU1gdEyFn3ytlnNJHVZ7bG4yjKpvVsmk-kwqZc-CWSfHLWDr20yl_3DDhuxJO5r_5KAGY2stoiFffK67QZdjBdsqjDlBsYE4K-CTc6jPnlqpdi-JwRfJww5TDjakW87APO87_YUV5_qfO9iIFnMoud_ntYLcnf7xR2Sg2q9MS_BYK70qxqmPwEaZMd5 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ethanolamine+Utilization+and+Bacterial+Microcompartment+Formation+Are+Subject+to+Carbon+Catabolite+Repression&rft.jtitle=Journal+of+bacteriology&rft.au=Kaval%2C+Karan+Gautam&rft.au=Gebbie%2C+Margo&rft.au=Goodson%2C+Jonathan+R&rft.au=Cruz%2C+Melissa+R&rft.date=2019-05-15&rft.pub=American+Society+for+Microbiology&rft.issn=0021-9193&rft.eissn=1098-5530&rft.volume=201&rft.issue=10&rft.spage=1&rft_id=info:doi/10.1128%2FJB.00703-18&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9193&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9193&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9193&client=summon |